title: Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development.
abstract: It is widely recognised that predicting or determining the absorption, distribution, metabolism and excretion (ADME) properties of a compound as early as possible in the drug discovery process helps to prevent costly late-stage failures. Although in recent years high-throughput in vitro absorption distribution metabolism excretion toxicity (ADMET) screens have been implemented, more efficient in silico filters are still highly needed to predict and model the most relevant metabolic and pharmacokinetic end points, and thereby accelerate drug discovery and development. The usefulness of the data generated and published for the chemist, biologist or project manager who ultimately wants to understand and optimise the ADME properties of lead compounds cannot be argued with. Collecting and comparing data is an overwhelming task for the time-pressed scientist. Aureus Pharma provides a uniquely specialised solution for knowledge generation in drug discovery. AurSCOPE(®) ADME/DDI (drug-drug interaction) is a fully annotated, structured knowledge database containing all the pertinent biological and chemical information on the metabolic properties of drugs. This Aureus knowledge database has proven to be highly useful in designing predictive models and identifying potential drug-drug interactions.
authors.affiliation: Aureus Pharma, 174 Quai de Jemmapes, 75010 Paris, France.
authors.forename: François
authors.initials: F
authors.lastname: Petitet
authors.forename: Olivier
authors.initials: O
authors.lastname: Barberan
authors.forename: Elodie
authors.initials: E
authors.lastname: Dubus
authors.forename: Ismail
authors.initials: I
authors.lastname: Ijjaali
authors.forename: Mary
authors.initials: M
authors.lastname: Donlan
authors.forename: Sophie
authors.initials: S
authors.lastname: Ollivier
authors.forename: André
authors.initials: A
authors.lastname: Michel